Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin P Rubio

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2018
Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in femalesDanuta Z Loesch, Flora Tassone, George D Mellick, et al.
Journal of Alzheimer'S Disease : JAD|July 17, 2010
Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in JapanBeena Koshy, Akinori Miyashita, Pamela St Jean, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Saliva-derived DNA performs well in large-scale, high-density single-nucleotide polymorphism microarray studiesMelanie Bahlo, Jim Stankovich, Patrick Danoy, et al.
Human Genetics|May 11, 2005
Identifying nineteenth century genealogical links from genotypesJim Stankovich, Melanie Bahlo, Justin P Rubio, et al.
Plos One|December 19, 2017
Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelinationYongfeng Chen, Wei Zhen, Tony Guo, et al.
Journal of Autoimmunity|April 15, 2008
CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosisFiona C McKay, Louisa I Swain, Stephen D Schibeci, et al.
The Journal of Infectious Diseases|October 27, 2015
Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax GenotypingHans-Peter Beck, Rahel Wampfler, Nick Carter, et al.
Nature Neuroscience|March 4, 2025
Neuronal somatic mutations are increased in multiple sclerosis lesionsAllan Motyer, Stacey Jackson, Bicheng Yang, et al.
European Journal of Clinical Pharmacology|August 23, 2014
Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravirIvy Song, Julie Borland, Shuguang Chen, et al.
Malaria Journal|February 19, 2016
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trialPamela L St Jean, Zhengyu Xue, Nick Carter, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Movement Disorders : Official Journal of the Movement Disorder Society|August 29, 2018
Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in femalesDanuta Z Loesch, Flora Tassone, George D Mellick, et al.
Journal of Alzheimer'S Disease : JAD|July 17, 2010
Genetic deficiency of plasma lipoprotein-associated phospholipase A2 (PLA2G7 V297F null mutation) and risk of Alzheimer's disease in JapanBeena Koshy, Akinori Miyashita, Pamela St Jean, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 5, 2010
Saliva-derived DNA performs well in large-scale, high-density single-nucleotide polymorphism microarray studiesMelanie Bahlo, Jim Stankovich, Patrick Danoy, et al.
Human Genetics|May 11, 2005
Identifying nineteenth century genealogical links from genotypesJim Stankovich, Melanie Bahlo, Justin P Rubio, et al.
Plos One|December 19, 2017
Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelinationYongfeng Chen, Wei Zhen, Tony Guo, et al.
Journal of Autoimmunity|April 15, 2008
CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosisFiona C McKay, Louisa I Swain, Stephen D Schibeci, et al.
The Journal of Infectious Diseases|October 27, 2015
Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax GenotypingHans-Peter Beck, Rahel Wampfler, Nick Carter, et al.
Nature Neuroscience|March 4, 2025
Neuronal somatic mutations are increased in multiple sclerosis lesionsAllan Motyer, Stacey Jackson, Bicheng Yang, et al.
European Journal of Clinical Pharmacology|August 23, 2014
Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravirIvy Song, Julie Borland, Shuguang Chen, et al.
Malaria Journal|February 19, 2016
Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trialPamela L St Jean, Zhengyu Xue, Nick Carter, et al.
Pageof 4